Synonyms: 1-(bis(4-fluorophenyl)methyl)-4-(2,3,4-trimethoxybenzyl)piperazine dihydrochloride; KB 2796; LOMERIZINE 2HCL; UNII-3W473D5LIY; KB 2796; KB-2796; 1-[BIS(4-FLUOROPHENYL)METHYL]-4-(2,3,4-TRIMETHOXYBENZYL)PIPERAZINE DIHYDROCHLORIDE; 1-[bis(4-fluorophenyl)methyl]-4-[(2,3,4-trimethoxyphenyl)methyl]piperazine dihydrochloride; 3W473D5LIY; MFCD01703867; 1-(bis(4-fluorophenyl)methyl)-4-(2,3,4-trimethoxybenzyl)piperazine dihydrochloride; 1-(2,3,4-Trimethoxybenzyl)-4-(bis(4-fluorophenyl)methyl)piperazine dihydrochloride; KB-2796; 1-(Bis(4-fluorophenyl)methyl)-4-((2,3,4-trimethoxyphenyl)methyl)piperazine dihydrochloride; DSSTox_CID_26427; DSSTox_RID_81605; DSSTox_GSID_46427; Piperazine, 1-(bis(4-fluorophenyl)methyl)-4-((2,3,4-trimethoxyphenyl)methyl)-, dihydrochloride; CAS-101477-54-7; NCGC00164543-01; lomerizine-hcl; Migsis; 1-(2,3,4-trimethoxybenzyl)-4-[bis(4-fluorophenyl)methyl]piperazine dihydrochloride; lomerizine; Terranas (TN); Lomerizine Hydrochlortde; AC1L3U0Y; C27H32Cl2F2N2O3; Lomerizine hydrochloride (JAN); SCHEMBL1153647; CHEMBL2356978; DTXSID1046427; C27H30F2N2O3.2HCl; CTK6J4130; lomerizine dihydrochloride; HY-B0768A; LOGVKVSFYBBUAJ-UHFFFAOYSA-N; BCP12061; Tox21_112172; DE-090; s4084; AKOS015900365; Tox21_112172_1; AC-2040; NCGC00164543-02; Lomerizine hydrochloride; AN-14347; H763; LS-110465; RT-013592; CS-0012057; FT-0627971; L0245; SW197640-2; A16599; D02633; 101477-54-7; 477L547; A800394; I14-0643; J-000407; Lomerizine dihydrochloride, >=98% (HPLC), powder; 101477-54-7, 101477-55-8(free base); 1-(bis(4-fluorophenyl)methyl)-4-(2,3,4-trimethoxybenzyl)piperazine hydrochloride; Piperazine, 1-[bis(4-fluorophenyl)methyl]-4-[(2,3,4-trimethoxyphenyl)methyl]-, hydrochloride (1:2); lomerizine; C27H30F2N2O3.2ClH; Lomerizine dihydrochloride; ACN-S001256; CID122125; CL0043; C27-H30-F2-N2-O3.2Cl-H; B1782; C052424; Lomerizine dihydrochloride, 99%, a new L- and T-type calcium channel blocker - 1G 1g; Lomerizine HCl; Terranas;